Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -89.02% is 513% below its 5-year average of -14.53%, around the middle of its 5-year range (-481.01%–525.81%).
As of the fiscal period ended Tuesday, March 31, 2026. 2105.85% below its 12-month average of 4.44%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-89.02%
NET PROFIT MARGIN AVG TTM
4.44%
NET PROFIT MARGIN AVG 3Y
-1.16%
NET PROFIT MARGIN AVG 5Y
-18.41%
NET PROFIT MARGIN AVG 10Y
26.53%
NET PROFIT MARGIN AVG 15Y
25.02%
NET PROFIT MARGIN AVG 20Y
6.53%
CURRENT VS TTM AVG
-2105.85%
CURRENT VS 3Y AVG
-7546.26%
CURRENT VS 5Y AVG
-383.43%
CURRENT VS 10Y AVG
-435.61%
CURRENT VS 15Y AVG
-455.87%
CURRENT VS 20Y AVG
-1464.29%
SECTOR MEDIAN · HEALTHCARE
9.05%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-1083.67%
vs the sector median at left
Bio-Rad Laboratories, Inc.
Market Cap
$8.85B
Net Profit Margin
-89.02%
TTM Avg
4.44%
3Y Avg
-1.16%
5Y Avg
-18.41%
Market Cap
$7.93B
Net Profit Margin
-0.30%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
Market Cap
$9.78B
Net Profit Margin
2.95%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
Market Cap
$10.18B
Net Profit Margin
8.56%
TTM Avg
7.89%
3Y Avg
6.46%
5Y Avg
6.98%
Market Cap
$10.37B
Net Profit Margin
-4.07%
TTM Avg
-4.03%
3Y Avg
-0.72%
5Y Avg
0.14%
Market Cap
$10.39B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$7.27B
Net Profit Margin
-22.20%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
Market Cap
$11.28B
Net Profit Margin
9.05%
TTM Avg
10.26%
3Y Avg
17.56%
5Y Avg
19.39%
Market Cap
$11.31B
Net Profit Margin
-4.59%
TTM Avg
-1.67%
3Y Avg
5.09%
5Y Avg
7.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $8.85B | -89.02% | 4.44% | -1.16% | -18.41% |
| Oscar Health, Inc. (OSCR)vs › | $7.93B | -0.30% | -1.75% | -5.71% | -20.27% |
| Henry Schein, Inc. (HSIC)vs › | $9.78B | 2.95% | 3.05% | 3.43% | 3.79% |
| Universal Health Services, Inc. (UHS)vs › | $10.18B | 8.56% | 7.89% | 6.46% | 6.98% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -4.07% | -4.03% | -0.72% | 0.14% |
| Molina Healthcare, Inc. (MOH)vs › | $10.39B | -0.02% | 1.97% | 2.41% | 2.58% |
| Tempus AI, Inc. (TEM)vs › | $7.27B | -22.20% | -60.53% | -62.93% | -77.31% |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 9.05% | 10.26% | 17.56% | 19.39% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.31B | -4.59% | -1.67% | 5.09% | 7.31% |
| Insulet Corp. (PODD)vs › | $11.82B | 10.44% | 14.66% | 10.46% | 7.35% |
Operating Margin
9.3%
Net Profit Margin
-89.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -89.02% |
| 2025-12-31 | 103.87% |
| 2025-09-30 | -52.36% |
| 2025-06-30 | 48.77% |
| 2025-03-31 | 10.93% |
| 2024-12-31 | -107.24% |
| 2024-09-30 | 100.53% |
| 2024-06-30 | -339.16% |
| 2024-03-31 | 62.85% |
| 2023-12-31 | 51.34% |
| 2023-09-30 | 16.81% |
| 2023-06-30 | -170.64% |
| 2023-03-31 | 10.19% |
| 2022-12-31 | 114.13% |
| 2022-09-30 | -24.12% |
| 2022-06-30 | -134.16% |
| 2022-03-31 | -481.01% |
| 2021-12-31 | -214.76% |
| 2021-09-30 | 525.81% |
| 2021-06-30 | 127.68% |
| 2021-03-31 | 134.48% |
| 2020-12-31 | 106.24% |
| 2020-09-30 | 203.14% |
| 2020-06-30 | 180.01% |
| 2020-03-31 | 119.99% |
| 2019-12-31 | 88.64% |
| 2019-09-30 | -46.16% |
| 2019-06-30 | 104.57% |
| 2019-03-31 | 156.18% |
| 2018-12-31 | -134.91% |
| 2018-09-30 | 49.41% |
| 2018-06-30 | 46.54% |
| 2018-03-31 | 119.08% |
| 2017-12-31 | 11.27% |
| 2017-09-30 | 5.12% |
| 2017-06-30 | 1.00% |
| 2017-03-31 | 2.48% |
| 2016-12-31 | -3.60% |
| 2016-09-30 | 3.62% |
| 2016-06-30 | 3.49% |
| 2016-03-31 | 2.61% |
| 2015-12-31 | 8.67% |
| 2015-09-30 | 3.70% |
| 2015-06-30 | 5.62% |
| 2015-03-31 | 3.77% |
| 2014-12-31 | 6.53% |
| 2014-09-30 | 2.17% |
| 2014-06-30 | 5.89% |
| 2014-03-31 | 1.31% |
| 2013-12-31 | 5.00% |
| 2013-09-30 | -1.41% |
| 2013-06-30 | 6.60% |
| 2013-03-31 | 3.90% |
| 2012-12-31 | 8.28% |
| 2012-09-30 | 8.50% |
| 2012-06-30 | 9.47% |
| 2012-03-31 | 6.38% |
| 2011-12-31 | 10.77% |
| 2011-09-30 | 8.89% |
| 2011-06-30 | 7.68% |
| 2011-03-31 | 6.81% |
| 2010-12-31 | 12.72% |
| 2010-09-30 | 9.49% |
| 2010-06-30 | 8.12% |
| 2010-03-31 | 7.67% |
| 2009-12-31 | 7.65% |
| 2009-09-30 | 8.36% |
| 2009-06-30 | 8.89% |
| 2009-03-31 | 7.55% |
| 2008-12-31 | -1.83% |
| 2008-09-30 | 6.30% |
| 2008-06-30 | 9.59% |
| 2008-03-31 | 6.28% |
| 2007-12-31 | 2.69% |
| 2007-09-30 | 8.23% |
| 2007-06-30 | 7.57% |
| 2007-03-31 | 8.37% |
| 2006-12-31 | 4.85% |
| 2006-09-30 | 7.60% |
| 2006-06-30 | 10.15% |
| 2006-03-31 | 10.12% |
| 2005-12-31 | 4.38% |
| 2005-09-30 | 5.73% |
| 2005-06-30 | 6.31% |
| 2005-03-31 | 11.20% |
| 2004-12-31 | 5.56% |
| 2004-09-30 | 2.43% |
| 2004-06-30 | 8.78% |
| 2004-03-31 | 8.24% |
| 2003-12-31 | 7.21% |
| 2003-09-30 | 3.90% |
| 2003-06-30 | 8.61% |
| 2003-03-31 | 10.72% |
| 2002-12-31 | 6.68% |
| 2002-09-30 | 7.39% |
| 2002-06-30 | 7.56% |
